Open AccessAntibiotics and proton pump inhibitors suppress the efficacy of immunotherapy against non‐small cell lung cancer
Author(s) -
Diao Xiayao
Publication year - 2020
Publication title -
thoracic cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.823
H-Index - 28
eISSN - 1759-7714
pISSN - 1759-7706
DOI - 10.1111/1759-7714.13470
Subject(s) - medicine , lung cancer , oncology , docetaxel , atezolizumab , cancer , chemotherapy , hazard ratio , clinical trial , immunotherapy , nivolumab , confidence interval